10x Genomics, Inc. TXG Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s total current liabilities?
- 10x Genomics, Inc. (TXG) reported total current liabilities of $113.6M in Q1 2026.
- How has 10x Genomics, Inc.'s total current liabilities changed year-over-year?
- 10x Genomics, Inc.'s total current liabilities increased by 5.3% year-over-year, from $107.9M to $113.6M.
- What is the long-term trend for 10x Genomics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total current liabilities has grown at a 5.4% compound annual growth rate (CAGR), from $118.13M to $153.45M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.